Intelligent Bio Solutions (INBS) Accounts Payables (2020 - 2025)

Intelligent Bio Solutions has reported Accounts Payables for 6 years, with the latest figure at $4.5 million in Q2 2025.

• For the quarter ending Q2 2025, Accounts Payables rose 166.01% year-over-year to $4.5 million; the trailing twelve-month figure through Jun 2025 stood at $4.5 million (up 166.01% YoY), and the FY2025 full-year result was $4.5 million, up 166.01% from the prior year.
• Accounts Payables for Q2 2025 stood at $4.5 million, up from $1.3 million in the prior quarter.
• The five-year high for Accounts Payables was $4.5 million in Q2 2025, with the low at $355447.0 in Q1 2023.
• Average Accounts Payables over 5 years is $1.7 million, with a median of $1.6 million recorded in 2021.
• Year-over-year, Accounts Payables slumped 59.8% in 2023 and soared 498.89% in 2024.
• Tracing INBS's Accounts Payables over 5 years: stood at $448886.0 in 2021, then soared by 313.35% to $1.9 million in 2022, then dropped by 4.98% to $1.8 million in 2023, then tumbled by 39.04% to $1.1 million in 2024, then soared by 321.9% to $4.5 million in 2025.
• The last three Accounts Payables figures came in at $4.5 million (Q2 2025), $1.3 million (Q1 2025), and $1.1 million (Q4 2024), per Business Quant data.

Peer Comparison